Home Test Page – InBios International, Inc.

Loading...

Home Test Pageinfo@inbios.com2019-08-26T22:56:33+00:00

Innovative Diagnostics for Public Health

InBios International develops and manufactures highly sensitive and specific immunodiagnostics for infectious diseases.

Our purpose is to serve the global marketplace with accurate, superior quality products that are easy to use and cost effective.

Zika Virus

InBios International, Inc. is developing an IgM ELISA for Zika virus. This kit is being designed to differentiate between Zika and other flaviviruses.

ZikaNew2

2016 Conference Exhibitions

AACC Annual Meeting, July 24-28, Chicago, IL

AACC Annual Meeting, Sept. 26-30, Atlanta, GA

ASTMH Annual Meeting, Nov. 17-21, 2021, National Harbor, MD

InBios in the News

FDA Grants First Marketing Rights for Anthrax Point-of-Care Test to InBios

InBios Awarded Funding for Lyme Disease Diagnostic from HHS, Cohen Foundation

Rapid Antigen Tests Accurately Detect COVID Variants

Read all News…

Zika • Chikungunya • Dengue • West Nile • Japanese Encephalitis • Scrub Typhus • Visceral Leishmaniasis • Cutaneous Leishmaniasis • Chagas • Filariasis • Strongyloides • Leptospirosis • Melioidosis • Norovirus